Find investors
← Back to all investors
Christopher College
ResearchedAngel Investors

Christopher College

Managing Partner

Angel InvestorsSeed Round
Pitch Christopher

Get their honest, personalized take on your startup.

Sign in to pitch Christopher

At a glance

Full Name
Christopher G. College
Title
Managing Partner & Co-Founder
Firm
TCP Venture Capital (Tech Council of Maryland / "TCP" — manages the Propel Baltimore Funds)
Firm Type
Early-stage venture capital firm (institutional seed / early-stage technology fund)
Investment Stage
Seed to Series A (post-seed companies with early, evaluable revenue)
Check Size
Not publicly disclosed (early-stage minority positions)
Target Company Profile
High-growth, scalable, capital-efficient technology companies with early commercial traction; explicitly not franchises, brick-and-mortar, online retail, biotech, or medical devices
Sector Focus
Software and unique technology applications — education technology, healthcare/health IT, and cybersecurity
Geographic Focus
Baltimore City, Maryland (portfolio companies are generally required to be headquartered in Baltimore)
Location
Baltimore, Maryland, USA

Background

Christopher College is a co-founder and the Managing Partner of TCP Venture Capital, a Baltimore-based early-stage technology venture firm he launched with Stuart Sutley in November 2012. He provides the strategic and operational leadership for the firm's family of funds, most notably the Propel Baltimore Funds (Propel I and Propel II), which were created to address the shortage of early-stage institutional capital available to technology startups in Baltimore City. The Propel effort was backed by founding support from the Abell Foundation and the France-Merrick Foundation.

Before founding TCP, College spent roughly two decades as a capital-markets and investment-banking professional. He served as Head of the Private Finance Group at Stifel Nicolaus (reported circa 2006–2012), and earlier held roles of increasing responsibility in the Private Finance Department of Legg Mason Wood Walker (2001–2006), where he had joined the investment-banking team in 1999 focusing on mergers, acquisitions, and IPOs in the technology and government-services industries. Earlier in his career (reported circa 1992–1997) he worked as an investment banker with Robert W. Baird & Co. Across his career he is credited with closing well over 60–100 transactions worth several billion dollars.

College holds a BA in Economics from Northwestern University and an MBA from Emory University. Through TCP, he has become a fixture of the Baltimore startup and civic-tech ecosystem, framing the firm's mission as not only generating returns but also creating high-paying jobs and helping Baltimore realize its potential as a destination for growing technology businesses.

Investment Thesis & Focus

  • Invests in early-stage technology companies that locate/headquarter in Baltimore City — geography is a core, intentional filter tied to the Propel funds' civic mandate.
  • Targets post-Series-Seed companies with early, evaluable revenue and demonstrable commercial readiness, typically underwriting toward a ~5-year exit horizon.
  • Focuses on high-growth, scalable, capital-efficient technology — concentrating on the region's strengths in edtech, healthcare/health IT, and cybersecurity.
  • Explicitly avoids franchises, brick-and-mortar operations, online retail, biotech, and medical devices.
  • Typically takes an active minority position, often with a board observer seat, and invests via preferred stock or convertible debt.
  • In his own words, the thesis is that overlooked local quality wins recognition: *"When we launched Propel, we knew there were strong companies here with the potential for greater success… there are great investment opportunities in the city – opportunities that others recognize too."*

Notable Investments

  • ZeroFox — Baltimore cybersecurity company; a flagship portfolio exit/success.
  • RedOwl Analytics — security analytics startup; grew to 60+ employees and was acquired by a Raytheon subsidiary (Forcepoint), which committed to keeping Baltimore operations.
  • Protenus — healthcare compliance/analytics platform; portfolio exit.
  • Rocket Doctor — telehealth platform; acquired by Treatment.com AI (Canada OTC-listed).
  • Infinity Bio — Baltimore biotech-adjacent company; received a Series A (mid-2025) tracked to TCP.
  • WellDoc — digital health / chronic-disease management pioneer (BlueStar).
  • Terbium Labs — dark-web data-intelligence firm (later acquired by Deloitte).
  • Link Labs — IoT / low-power wireless connectivity company.
  • Qualytics, EcoMap Technologies, Traitify, Yet Analytics, Pixelligent, Snag-A-Slip, Minnowtech, SocialToaster, Indicio, Pixee AI, Real Time Medical Systems, Cerebro, InsightIn Health, Impruvon Health — additional active/edtech/health/cyber portfolio holdings.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.